268 related articles for article (PubMed ID: 23601855)
1. Heparin increases the infectivity of Human Papillomavirus type 16 independent of cell surface proteoglycans and induces L1 epitope exposure.
Cerqueira C; Liu Y; Kühling L; Chai W; Hafezi W; van Kuppevelt TH; Kühn JE; Feizi T; Schelhaas M
Cell Microbiol; 2013 Nov; 15(11):1818-36. PubMed ID: 23601855
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin Sulfate Proteoglycans Are De Facto Cellular Receptors for Human Papillomavirus 16 under High Serum Conditions.
Fons NR; Kines RC; Thompson CD; Day PM; Lowy DR; Schiller JT
J Virol; 2022 Apr; 96(7):e0185721. PubMed ID: 35285688
[TBL] [Abstract][Full Text] [Related]
3. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.
Johnson KM; Kines RC; Roberts JN; Lowy DR; Schiller JT; Day PM
J Virol; 2009 Mar; 83(5):2067-74. PubMed ID: 19073722
[TBL] [Abstract][Full Text] [Related]
4. Further evidence that papillomavirus capsids exist in two distinct conformations.
Selinka HC; Giroglou T; Nowak T; Christensen ND; Sapp M
J Virol; 2003 Dec; 77(24):12961-7. PubMed ID: 14645552
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.
Selinka HC; Florin L; Patel HD; Freitag K; Schmidtke M; Makarov VA; Sapp M
J Virol; 2007 Oct; 81(20):10970-80. PubMed ID: 17686860
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition.
Day PM; Thompson CD; Buck CB; Pang YY; Lowy DR; Schiller JT
J Virol; 2007 Aug; 81(16):8784-92. PubMed ID: 17553881
[TBL] [Abstract][Full Text] [Related]
7. The papillomavirus major capsid protein L1.
Buck CB; Day PM; Trus BL
Virology; 2013 Oct; 445(1-2):169-74. PubMed ID: 23800545
[TBL] [Abstract][Full Text] [Related]
8. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.
Shafti-Keramat S; Handisurya A; Kriehuber E; Meneguzzi G; Slupetzky K; Kirnbauer R
J Virol; 2003 Dec; 77(24):13125-35. PubMed ID: 14645569
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors.
Jiang J; Wu X; Tang H; Luo G
PLoS One; 2013; 8(7):e67982. PubMed ID: 23844141
[TBL] [Abstract][Full Text] [Related]
10. Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA.
Rommel O; Dillner J; Fligge C; Bergsdorf C; Wang X; Selinka HC; Sapp M
J Med Virol; 2005 Jan; 75(1):114-21. PubMed ID: 15543569
[TBL] [Abstract][Full Text] [Related]
11. Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16.
Richards KF; Bienkowska-Haba M; Dasgupta J; Chen XS; Sapp M
J Virol; 2013 Nov; 87(21):11426-37. PubMed ID: 23966387
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.
Becker M; Greune L; Schmidt MA; Schelhaas M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593032
[TBL] [Abstract][Full Text] [Related]
14. The evolving field of human papillomavirus receptor research: a review of binding and entry.
Raff AB; Woodham AW; Raff LM; Skeate JG; Yan L; Da Silva DM; Schelhaas M; Kast WM
J Virol; 2013 Jun; 87(11):6062-72. PubMed ID: 23536685
[TBL] [Abstract][Full Text] [Related]
15. Target cell cyclophilins facilitate human papillomavirus type 16 infection.
Bienkowska-Haba M; Patel HD; Sapp M
PLoS Pathog; 2009 Jul; 5(7):e1000524. PubMed ID: 19629175
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
[TBL] [Abstract][Full Text] [Related]
17. Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.
Surviladze Z; Dziduszko A; Ozbun MA
PLoS Pathog; 2012 Feb; 8(2):e1002519. PubMed ID: 22346752
[TBL] [Abstract][Full Text] [Related]
18. Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate.
Knappe M; Bodevin S; Selinka HC; Spillmann D; Streeck RE; Chen XS; Lindahl U; Sapp M
J Biol Chem; 2007 Sep; 282(38):27913-22. PubMed ID: 17640876
[TBL] [Abstract][Full Text] [Related]
19. Binding of rat thyroglobulin to heparan sulfate proteoglycans.
Marinò M; Andrews D; McCluskey RT
Thyroid; 2000 Jul; 10(7):551-9. PubMed ID: 10958307
[TBL] [Abstract][Full Text] [Related]
20. Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35.
Tuve S; Wang H; Jacobs JD; Yumul RC; Smith DF; Lieber A
PLoS Pathog; 2008 Oct; 4(10):e1000189. PubMed ID: 18974862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
